JFB vs WST · rev $30.5M vs P/E 35, rev $1.72B
JFB Construction Holdings Class A Common Stock (JFB) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
JFB Construction Holdings Class A Common Stock (JFB) is a real estate - development company listed on NASDAQ.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported JFB revenue for 2025-12-31 was $30.5M. Net income was -$5.3M. Revenue was up 32.3% from 2024-12-31 to 2025-12-31. JFB currently screens at market cap $77.4M.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
JFB currently screens at market cap $77.4M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the JFB and WST stock pages for the full models.
Not investment advice.